TSC-36/FRP inhibits vascular smooth muscle cell proliferation and migration

Experimental and Molecular Pathology

Volumn 80, Issue 2, 2006, Pages 132-140

  Liu, Shu ^a,b   Wang, Luya ^b   Wang, Wei ^c   Lin, Jie ^a   Han, Jing ^c   Sun, Haiyan ^a   Guo, Hengyi ^a   Sun, Renyu ^a   Wu, Qixia ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Beijing Chinese Medical and Chinese Medicine College   (China)

Author keywords

Daidzein; Restenosis; TSC 36; Vascular smooth muscle cell

Indexed keywords

DAIDZEIN; ESTRADIOL; FOLLISTATIN RELATED PROTEIN; MESSENGER RNA; POLYCLONAL ANTIBODY; PROTEIN ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON; CAROTID ARTERY INJURY; CELL ASSAY; CELL CYCLE G2 PHASE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNIZATION; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; INTIMA; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RABBIT; RAT; SMOOTH MUSCLE FIBER; UMBILICAL ARTERY; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERIES; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; FOLLISTATIN-RELATED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOFLAVONES; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RNA, MESSENGER;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 33644501780     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2005.07.005     Document Type: Article

References (29)

1. P. Bornstein Thrombospondins as matricelluar modulators of cell function J. Clin. Invest. 107 2001 929 934
2. P. Bornstein, and E.H. Sage Matricellular proteins: extracellular modulators of cell function Curr. Opin. Cell Biol. 14 2002 608 616
3. N.M. Borradaile, L.E. de Dreu, L.J. Wilcox, J.Y. Edwards, and M.W. Huff Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms Biochem. J. 366 2002 531 539
4. R.C. Braun-Dullaeus, M.J. Mann, and V.J. Dzau Cell cycle progression. New therapeutic target for vascular proliferative disease Circulation 98 1998 82 89
5. A.C. Gittenberger-de Groot, M.C. DeRuiter, M. Bergwerff, and R.E. Poelmann Smooth muscle cell origin and its relation to heterogeneity in development and disease Arterioscler. Thromb. Vasc. Biol. 19 1999 1589 1594
6. C.J. Gruber, W. Tschugguel, C. Schneeberger, and J.C. Huber Production and actions of estrogens N. Engl. J. Med. 346 2002 340 352
7. H.O. Hambrock, B. Kaufmann, S. Muller, F.G. Hanisch, K. Nose, M. Paulsson, P. Maurer, and U. Hartmann Structural characterization of TSC-36/Flik: analysis of two charge isoforms J. Biol. Chem. 279 2004 11727 11735
8. J.L. Hillebrands, F.A. Klatter, and J. Rozing Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis Arterioscler. Thromb. Vasc. Biol. 23 2003 380 387
9. B. Holifield, T. Helgason, S. Jemelka, A. Taylor, S. Navran, J. Allen, and C. Seidel Differentiated vascular myocytes: are they involved in neointimal formation? J. Clin. Invest. 97 1996 814 825
10. M. Jakacka, M. Ito, J. Weiss, P.Y. Chien, B.D. Gehm, and J.L. Jameson Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway J. Biol. Chem. 276 2001 13615 13621
11. I. Johnston, H.J. Spence, J.N. Winnie, L. McGarry, J.K. Vass, L. Meagher, G. Stapleton, and B.W. Ozanne Regulation of a multigenic invasion programme by the transcription factor, AP-1: re-expression of a down-regulated gene, TSC-36, inhibits invasion Oncogene 19 2000 5348 5358
12. R.H. Karas, B.L. Patterson, and M.E. Mendelsohn Human vascular smooth muscle cells contain functional estrogen receptors Circulation 89 1994 1943 1950
13. H.P. Kim, J.Y. Lee, J.K. Jeong, S.W. Bae, H.K. Lee, and I. Jo Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae Biochem. Biophys. Res. Commun. 263 1999 257 262
14. D. Kim-Schulze, K.A. McGowan, S.C. Hubchak, M.C. Cid, M.B. Martin, H.K. Kleinman, G.L. Greene, and H.W. Schnaper Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells Circulation 94 1996 1402 1407
15. C. Kupprion, K. Motamed, and E.H. Sage SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells J. Biol. Chem. 273 1998 29635 29640
16. T. Lauber, U.C. Marx, A. Schulz, P. Kreutzmann, P. Rosch, and S. Hoffmann Accurate disulfide formation in Escherichia coli overexpression and characterization of the first domain (HF6478) of the multiple Kazal-type inhibitor LEKTI Protein Expression Purif. 22 2001 108 112
17. M.J. Leskinen, P.T. Kovanen, and K.A. Lindstedt Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells-A potential mechanism for the weakening and rupture of atherosclerotic plaques Biochem. Pharmacol. 15 2003 1493 1498
18. 2-induced cytotoxicity in 'epithelioid' smooth muscle cells: implications for neointimal regression Arterioscler. Thromb. Vasc. Biol. 20 2000 1473 1479
19. G. Martin, and R.J. Mairs Synthesis of quantitation standards for nested competitive PCR for the determination of minimal residual disease in B-lineage acute lymphoblastic leukaemia Leuk. Res. 21 1997 807 809
20. J. Mashimo, R. Maniwa, H. Sugino, and K. Nose Decrease in the expression of a novel TGF beta1-inducible and ras-recision gene, TSC-36, in human cancer cells Cancer Lett. 113 1997 213 219
21. K. Motamed, S.E. Funk, H. Koyama, R. Ross, E.W. Raines, and E.H. Sage Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors J. Cell. Biochem. 84 2002 759 771
22. K. Motamed, D.J. Blake, J.C. Angello, B.L. Allen, A.C. Rapraeger, S.D. Hauschka, and E.H. Sage Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A J. Cell. Biochem. 90 2003 408 423
23. T. Ohashi, S. Sato, A. Yoshiki, and M. Kusakabe TSC-36 (Follistatin-Related Polypeptide) gene expression in estrogen receptor positive osteoblastic cell line, CDO7F Calcif. Tissue Int. 61 1997 400 403
24. E.H. Sage Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis Trends Cell Biol. 7 1997 182 186
25. M. Shibanuma, J. Mashimo, A. Mita, T. Kuroki, and K. Nose Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide Eur. J. Biochem. 217 1993 13 19
26. K. Sumitomo, A. Kurisaki, N. Yamakawa, K. Tsuchida, E. Shimizu, S. Sone, and H. Sugino Expression of a TGF-beta1 inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines Cancer Lett. 155 2000 37 46
27. Q. Yan, and E.H. Sage SPARC, a matricellular glycoprotein with important biological functions J. Histochem. Cytochem. 47 1999 1495 1506
28. A. Zalewski, Y. Shi, and A.G. Johnson Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond? Circ. Res. 91 2002 652 655
29. A. Zwijsen, H. Blockx, W. Van Arnhem, J. Willems, L. Fransen, K. Devos, J. Raymackers, A. Van de Voorde, and H. Slegers Characterization of a rat C6 glioma-secreted follistatin-related protein (FRP). Cloning and sequence of the human homologue Eur. J. Biochem. 225 1994 937 946